Select Medical Holdings (SEM) EBIT Margin (2018 - 2026)

Select Medical Holdings (SEM) has 9 years of EBIT Margin data on file, last reported at 6.92% in Q1 2026.

• EBIT Margin for Q1 2026 came in at 6.92%, down 141.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.83% (up 80.0% YoY), and the FY2025 annual result was 6.17%, up 99.0% from the prior year.
• EBIT Margin climbed to 6.92% in Q1 2026 per SEM's latest filing, from 4.58% in the prior quarter.
• Over five years, EBIT Margin peaked at 120.13% in Q4 2022 and troughed at 14.23% in Q4 2023.
• A 5-year average of 12.63% and a median of 6.5% in 2022 frame the typical range for EBIT Margin.
• The sharpest annual moves came in 2022 and 2023: EBIT Margin jumped 11516 bps in 2022, then sank 13436 bps in 2023.
• A 5-year view of EBIT Margin shows it stood at 120.13% in 2022, then plunged by 112 bps to 14.23% in 2023, then soared by 111 bps to 1.61% in 2024, then soared by 185 bps to 4.58% in 2025, then soared by 51 bps to 6.92% in 2026.
• Business Quant data shows SEM's EBIT Margin at 6.92% in Q1 2026, 4.58% in Q4 2025, and 5.35% in Q3 2025.